Approval · Notice of Compliance 20399 · 2018
VALIUM: Notice of Compliance 20399
Issued January 22, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20399
- Date
- January 22, 2018
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To align all packaging components for valium (5 mg labels) with the plain language labelling regulation requirements
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALIUM | Not yet assigned | — |
Medicinal ingredients
- DIAZEPAM 5 MG per TAB